Pack de 10 frascos2 em stockPoupe 17%Tesamorelin 5 mg
Análogo estabilizado de GHRH
Tesamorelin GHRH analogue research peptide, Australian-shipped. Lab-verified ≥99% purity.
Apenas para uso em investigação. Este composto é vendido estritamente para investigação in vitro e fins laboratoriais e não se destina ao consumo humano nem a uso terapêutico. Ao comprar, confirma que é um investigador qualificado e aceita o nosso aviso legal completo.
Restam apenas 2 packs
Análogo estabilizado da hormona libertadora da hormona de crescimento, estudado pelos efeitos sobre o tecido adiposo visceral e a atividade do eixo IGF-1 em modelos de investigação.
Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) — modified to extend its half-life relative to native GHRH. It is one of the most studied GHRH-analogue research peptides and the only one of its class to have undergone regulatory approval in any jurisdiction (for HIV-associated lipodystrophy, in the US, under the brand name Egrifta). Quantum Labs supplies Tesamorelin as a lyophilised powder for Australian research applications.
Research on Tesamorelin has covered models of growth-hormone secretion, body composition, lipid metabolism, and IGF-1 dynamics. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mecanismo
Estudado pela ligação seletiva ao recetor de GHRH com semivida prolongada. Investigação associada à redução de marcadores de gordura visceral e à elevação de IGF-1 em populações de estudo.
Verificado por HPLC face a uma especificação de pureza ≥99 %. Testado de forma independente por laboratórios terceiros acreditados.
Tesamorelin — perguntas frequentes
What is Tesamorelin?
Tesamorelin is a stabilised synthetic analogue of growth-hormone-releasing hormone (GHRH). It is studied in growth-hormone research and pre-clinical models of metabolic regulation and body composition.
Is Tesamorelin legal in Australia?
Tesamorelin is not approved as a therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Tesamorelin for research use only.
What is the difference between Tesamorelin and CJC-1295?
Both are GHRH-analogue research peptides. CJC-1295 has a longer half-life and a stronger ability to extend the duration of GH pulses; Tesamorelin's modifications produce a shorter-acting but well-characterised GHRH-mimicking profile. They are studied as parallel research tools for different aspects of GHRH-pathway signalling.
What is the typical Tesamorelin research dosage?
Published clinical research (in the US, for the approved indication) has used 2 mg daily subcutaneous Tesamorelin. Research-protocol dosing varies by model. Human therapeutic dosing is not established in Australia.
Guias relacionados com Tesamorelin
Os investigadores também exploram
Em destaquePack de 10 frascosPoupe 25%Retatrutide
Pó liofilizado10 mg · 8 strengths
Péptido de investigação triagonista de GLP-1 / GIP / glucagon
Em 1 combinação
Pack de 10 frascosPoupe 22%MOTS-c
Pó liofilizado10 mg · 2 strengths
Péptido metabólico de origem mitocondrial
Em 2 combinações
Pack de 10 frascosPoupe 16%5-Amino-1MQ
Pó liofilizado50 mg · 3 strengths
Composto de investigação inibidor de NNMT